Analysis of State Cannabis Laws and Dispensary Staff Recommendations to Adults Purchasing Medical Cannabis.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
entrez:
15
9
2021
pubmed:
16
9
2021
medline:
11
1
2022
Statut:
epublish
Résumé
Over the last decade, cannabis has become more accessible through the proliferation of dispensaries in states that have legalized its use. Most patients using cannabis for medical purposes report getting advice from dispensaries, yet there has been little exploration of frontline dispensary staff practices. To describe the practices of frontline dispensary workers who interact with customers purchasing cannabis for medical purposes and assess whether dispensary practices are associated with medicalization of state cannabis laws (degree to which they resemble regulation of prescription or over-the-counter drugs) and statewide adult use. This nationwide cross-sectional survey study was conducted from February 13, 2020, to October 2, 2020, using an online survey tool. Potential respondents were eligible if they reported working in a dispensary that sells tetrahydrocannabinol-containing products and interacting with customers about cannabis purchases. Participant responses to questions about formulating customer recommendations and talking to customers about risks. The 434 survey responses from 351 unique dispensaries were most often completed by individuals who identified as budtenders (40%), managers (32%), and pharmacists (13%). Most respondents reported basing customer recommendations on the customer's medical condition (74%), the experiences of other customers (70%), the customer's prior experience with cannabis (67%), and the respondent's personal experience (63%); fewer respondents relied on clinician input (40%), cost (45%), or inventory (12%). Most respondents routinely advised customers about safe storage and common adverse effects, but few counseled customers about cannabis use disorder, withdrawal, motor vehicle collision risk, or psychotic reactions. A higher state medicalization score was significantly associated with using employer training (odds ratio, 1.41; 95% CI, 1.18-1.67) and physician or clinician input (odds ratio, 1.23; 95% CI, 1.05-1.43) as a basis for recommendation. Medicalization score was not associated with counseling about cannabis risks. This survey study provides insight into how frontline dispensary staff base cannabis recommendations and counsel about risks. The findings may have utility for clinicians to counsel patients who purchase cannabis, customers who want to be prepared for a dispensary visit, and policy makers whose decisions affect cannabis laws.
Identifiants
pubmed: 34524435
pii: 2784114
doi: 10.1001/jamanetworkopen.2021.24511
pmc: PMC8444019
doi:
Substances chimiques
Medical Marijuana
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2124511Commentaires et corrections
Type : CommentIn
Références
Drugs (Abingdon Engl). 2020;27(1):69-78
pubmed: 31949332
Fam Pract. 2021 Jul 28;38(4):479-483
pubmed: 33558870
J Gen Intern Med. 2020 Jun;35(6):1875-1878
pubmed: 31898125
Am J Public Health. 2017 Aug;107(8):e1-e12
pubmed: 28644037
J Pain. 2019 Nov;20(11):1362-1372
pubmed: 31132510
Addict Sci Clin Pract. 2019 Dec 2;14(1):42
pubmed: 31787111
Cannabis Cannabinoid Res. 2016 Dec 01;1(1):244-251
pubmed: 28861496
Cannabis. 2018;1(2):22-35
pubmed: 31304464
Subst Abuse. 2017 Aug 21;11:1178221817725515
pubmed: 28855796
Int J Drug Policy. 2021 Aug;94:103202
pubmed: 33765514
Pain Med. 2020 Nov 1;21(11):3180-3186
pubmed: 31909803
Am J Hosp Palliat Care. 2017 Feb;34(1):85-91
pubmed: 26377551
Ann Intern Med. 2018 Sep 4;169(5):282-290
pubmed: 30039154
Drug Alcohol Depend. 2015 Apr 1;149:232-44
pubmed: 25735467